Cancer BiologyAdvanced SciencePeer-reviewed
KRAS withdrawal in Cholangiocarcinoma leads to immune infiltration and tumor regression
Youwei Qiao, Matthew F. Yee, Chaitanya Naimesh Parikh…·Wen Xue
This study shows that removing KRASG12D in a mouse model of cholangiocarcinoma leads to tumor regression through immune infiltration and activation of CD8+ T cells.